Aspirin Use among Adults with Cardiovascular Disease in the United States: Implications for an Intervention Approach

Aspirin for primary prevention of cardiovascular disease

(2018) Davide Capodanno et al.   LANCET

Aspirin for Prevention of Cardiovascular Disease

(2017) Vincent L. Mendy et al.   Preventing Chronic Disease

2016 European Guidelines on cardiovascular disease prevention in clinical practice

(2016) Massimo F. Piepoli et al.   EUROPEAN HEART JOURNAL

Aspirin for Primary and Secondary Prevention of Cardiovascular Disease

(2016) Robert W. Godley et al.   TEXAS HEART INSTITUTE JOURNAL

Trends in HIV Testing among Adults in Georgia: Analysis of the 2011–2015 BRFSS Data

(2016) Benjamin Ansa et al.   International Journal of Environmental Research and Public Health

Aspirin for Primary and Secondary Prevention of Cardiovascular Disease

(2016) Robert W. Godley et al.   TEXAS HEART INSTITUTE JOURNAL

Use of Low-Dose Aspirin as Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults (from the National Health Interview Survey, 2012)

(2015) Jing Fang et al.   AMERICAN JOURNAL OF CARDIOLOGY

Population Trends in Aspirin Use for Cardiovascular Disease Prevention 1980–2009: The Minnesota Heart Survey

(2015) Russell V. Luepker et al.   Journal of the American Heart Association

Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy

(2011) Timothy D. Warner et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines Executive Summary

(2011) Alan D. Bell et al.   CANADIAN JOURNAL OF CARDIOLOGY